Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RAWGA is a South Korean health and beauty company specializing in the development of plant-based collagen solutions for the global wellness market. The company is best known for its proprietary technology that extracts low-molecular-weight collagen peptides from hibiscus, providing a 100% vegan alternative to animal-derived collagen. Their product portfolio includes a variety of functional foods, dietary supplements, and inner beauty products designed to support skin elasticity, hydration, and overall health. RAWGA emphasizes clean-label formulations, avoiding synthetic additives and focusing on high-absorption nutrient delivery. By bridging the gap between biotechnology and nutrition, the company caters to the growing consumer demand for sustainable and cruelty-free health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RAWGA.